Integra Lifesciences Holdings Corp

IARTNASDAQ · USD
16.20USD+0.51 (+3.22%)
697

Integra Lifesciences Holdings Corp (IART) Covered Calls

As of September 15, 2026, IART has 5 covered call opportunities in the coming three months. Return ranges from 16.1 to 45.5% until expiration. Annualized return ranges from 34.3 to 169.4%. The nearest expiration is December 18, 2026. Maximum potential profit is $705.

Read more

Running IART covered calls helps you generate consistent income from Integra Lifesciences Holdings Corp's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Integra Lifesciences Holdings Corp involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best IART covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if IART stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling IART covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Integra Lifesciences Holdings Corp covered call is worth writing.

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services.

It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Income-focused investors, long-term IART holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling IART covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Integra Lifesciences Holdings Corp covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV percentile36.11% Neutral
  • Market cap (M$)1,220
  • 52 weeks high-23.43%
  • 52 weeks low80.34%
  • Analyst recommendationHold
    2.75
  • Target price$19.56
    20.78% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-10-29
  • P/E
  • Future P/E6.01
  • EPS (ttm)-0.09
  • EPS growth next 5 years8.53%

As of September 15, 2026

2026-12-189822.5045.160.050.45705.0045.48169.40-0.32+0.134140.40
2026-12-189820.0029.030.252.45475.0030.65114.14-1.61+0.37482.20
2026-12-189817.5012.900.502.35250.0016.1360.07-3.23+0.44581.85
2027-03-1918920.0029.030.053.40455.0029.3556.69-0.32+0.41383.35
2027-03-1918917.5012.900.753.50275.0017.7434.26-4.84+0.501432.75

As of September 15, 2026

Sell covered calls with the data behind you

Find the best IART covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial